Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma

BACKGROUND: Large randomised clinical trials and systematic reviews substantiate that tamoxifen is ineffective in improving survival of patients with hepatocellular carcinoma (HCC). However, a recent report suggested that the drug might prolong survival among patients with well preserved liver funct...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gallo, Ciro, De Maio, Ermelinda, Di Maio, Massimo, Signoriello, Giuseppe, Daniele, Bruno, Pignata, Sandro, Annunziata, Annalisa, Perrone, Francesco
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2006
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1555599/
https://ncbi.nlm.nih.gov/pubmed/16863588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars